Valtech Cardio

Specializes in the development of technologically advanced, clinically proven devices for mitral and tricuspid valve repair and replacement.

Health Tech & Life Sciences
Acquired by Edwards Lifesciences Corporation
Acquired Or Yehuda, Israel Founded 2005
Last updated 2026-07-26
Total raised
$19.7M
Last: Undisclosed Round 2010-03
Stage
Acquired
Founded
2005
Headcount
1-10
HQ
Or Yehuda, Israel
Sector
Health Tech & Life Sciences

About

Valtech Cardio, Ltd. was an Israeli company specializing in the development of devices for mitral and tricuspid valve repair and replacement. The company had full in-house development, manufacturing, and clinical research capabilities. Its flagship product was the Cardioband System for transcatheter repair of the mitral and tricuspid valves. Valtech Cardio was acquired by Edwards Lifesciences in January 2017 for $340 million in stock and cash, with potential for up to $350 million in additional milestone payments.

Funding history · 2 rounds · $19.7M total

2010-02
B Round $17.8M
★ NGN Capital★ OXO Ventures
2006-08
A Round $1.9M
★ Peregrine Ventures

Headcount over time

From 31 (2017-11) to 40 (2026-07) · +9 (+29%) · 3 points · source: Finder history + radar grounding
400 2017-11 2026-07

Q&A

What is Valtech Cardio's primary focus?
Valtech Cardio specialized in the development of technologically advanced, clinically proven devices for mitral and tricuspid valve repair and replacement.
When was Valtech Cardio founded?
Valtech Cardio was founded in 2005.
What was the total amount of funding raised by Valtech Cardio?
Valtech Cardio raised a total of $47.8 million.
Which investors participated in Valtech Cardio's B Round funding?
In February 2010, Valtech Cardio completed a B Round with participation from.
When was Valtech Cardio acquired and by whom?
Valtech Cardio was acquired by Edwards Lifesciences Corporation in January 2017.
What was the acquisition amount for Valtech Cardio?
Edwards Lifesciences Corporation acquired Valtech Cardio for $340 million in January 2017, with potential for up to $350 million in additional milestone payments.
What is Valtech Cardio's employee count?
Valtech Cardio had 1-10 employees.
What was a key product developed by Valtech Cardio?
Valtech Cardio's flagship product was the Cardioband System for transcatheter repair of the mitral and tricuspid valves.

Team · 3

Amir Gross
Founder · CEO
Peregrine Ventures
Founder · Co-founder
Yossi Gross
Founder · Co-founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

cardiologysurgeryvalvesmedical-devicesminimally-invasivehospitalssurgeonsdoctors
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitewww.valtechcardio.com
LinkedInlinkedin.com/company/6490611
YouTubeyoutube.com/channel/UC7tWMRZI8LvxuDrWvzLBEHw

Identifiers & details

Legal nameValtech Cardio, Ltd.
Founded2005
Status reasonAcquired (Inactive) by Edwards Lifesciences on Jan 2017 - closed due to acquisition

Acquisitions & public offerings

Acquired by Edwards Lifesciences Corporation 2017-01 $340.0M

Radar intelligence

Patents

EPO59

Web history (Wayback)

Domainvaltechcardio.com

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)513850057
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2006-07-04
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events1 — annual_report (1)
Registered addressהטוחן 17 קיסריה

Recent registry events

DateEvent
2025-12-25דו~ח שנתי-הסרת בעל תפקיד